594 related articles for article (PubMed ID: 33706773)
1. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
[TBL] [Abstract][Full Text] [Related]
2. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Likwela JL; De Mol P; Okitolonda EW; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2020 Mar; 19(1):121. PubMed ID: 32197607
[TBL] [Abstract][Full Text] [Related]
3. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
[TBL] [Abstract][Full Text] [Related]
5. Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Akilimali PZ; Situakibanza HNT; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
BMC Infect Dis; 2022 Feb; 22(1):145. PubMed ID: 35144535
[TBL] [Abstract][Full Text] [Related]
6. The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Bontems S; Kabututu PZ; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
PLoS One; 2020; 15(8):e0237791. PubMed ID: 32822392
[TBL] [Abstract][Full Text] [Related]
7. Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.
Koukouikila-Koussounda F; Jeyaraj S; Nguetse CN; Nkonganyi CN; Kokou KC; Etoka-Beka MK; Ntoumi F; Velavan TP
Malar J; 2017 Apr; 16(1):155. PubMed ID: 28420403
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.
Ljolje D; Dimbu PR; Kelley J; Goldman I; Nace D; Macaia A; Halsey ES; Ringwald P; Fortes F; Udhayakumar V; Talundzic E; Lucchi NW; Plucinski MM
Malar J; 2018 Feb; 17(1):84. PubMed ID: 29458380
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
11. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.
Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M;
Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353
[TBL] [Abstract][Full Text] [Related]
12. SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA.
Beavogui AH; Diawara EY; Cherif MS; Delamou A; Diallo N; Traore A; Millimouno P; Camara D; Sylla MM; Toure AA; Diallo MS; Toure S; Togo A; Camara G; Kourouma K; Sagara I; Dicko A; Djimde A
J Parasitol; 2021 Sep; 107(5):778-782. PubMed ID: 34581793
[TBL] [Abstract][Full Text] [Related]
13. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
[TBL] [Abstract][Full Text] [Related]
14. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.
Cheng W; Song X; Tan H; Wu K; Li J
Malar J; 2021 May; 20(1):209. PubMed ID: 33933099
[TBL] [Abstract][Full Text] [Related]
15. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
[TBL] [Abstract][Full Text] [Related]
16. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.
Antonia AL; Taylor SM; Janko M; Emch M; Tshefu AK; Meshnick SR
Am J Trop Med Hyg; 2014 Jun; 90(6):1094-7. PubMed ID: 24732459
[TBL] [Abstract][Full Text] [Related]
19. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.
Folarin OA; Bustamante C; Gbotosho GO; Sowunmi A; Zalis MG; Oduola AM; Happi CT
Acta Trop; 2011 Dec; 120(3):224-30. PubMed ID: 21920347
[TBL] [Abstract][Full Text] [Related]
20. Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.
Idowu AO; Oyibo WA; Bhattacharyya S; Khubbar M; Mendie UE; Bumah VV; Black C; Igietseme J; Azenabor AA
Malar J; 2019 Sep; 18(1):319. PubMed ID: 31533729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
